Shigellosis: antibiotics should be strictly reserved for severe disease and cases at very high risk of onward transmission
Increasing rates of multidrug-resistant (MDR) and extensively drug-resistant (XDR) <i>Shigella</i> have been detected worldwide. This retrospective review of shigellosis notifications in Southeast Queensland found that XDR <i>Shigella</i> accounted for 48% of notifications. Antimicrobial treatment should be reserved for individuals with severe disease, immunocompromise or high risk of onward transmission.
Authors
- Asha Kakkanat (ORCID: https://orcid.org/0000-0002-2492-1424)
- Rikki Graham (ORCID: https://orcid.org/0000-0002-4100-9656)
- Bhakti R. Vasant
- Russell Stafford (ORCID: https://orcid.org/0000-0001-6517-1685)
- Kate Alexander
- Robert Bell
- Mark Stickley
- Megan Young
- Amy Jennison
Institutions
- Queensland Health (AU)
- The University of Queensland (AU)
- Gold Coast Health (AU)
Publication Details
- Journal
- Communicable Diseases Intelligence
- Published
- 2026-03-23
- DOI
- https://doi.org/10.33321/cdi.2026.50.026
- Primary Topic
- Escherichia coli research studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00